These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 30114965)

  • 1. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chaudhary M; Sehgal D
    J Biomol Struct Dyn; 2022; 40(22):11560-11570. PubMed ID: 34355667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell-based approaches.
    Chaudhary M; Kumar A; Bala Sharma K; Vrati S; Sehgal D
    FEBS J; 2024 Jun; 291(12):2656-2673. PubMed ID: 38303163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds.
    Vora J; Patel S; Athar M; Sinha S; Chhabria MT; Jha PC; Shrivastava N
    J Biomol Struct Dyn; 2020 Apr; 38(6):1726-1740. PubMed ID: 31057055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Inhibitor Binding Combined with Reactivity Studies to Discover the Potentially Inhibiting Phytochemicals Targeting Chikungunya Viral Replication.
    Rasool N; Bakht A; Hussain W
    Curr Drug Discov Technol; 2021; 18(3):437-450. PubMed ID: 32164512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors.
    El-labbad EM; Ismail MA; Abou Ei Ella DA; Ahmed M; Wang F; Barakat KH; Abouzid KA
    Chem Biol Drug Des; 2015 Dec; 86(6):1518-27. PubMed ID: 26212366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus.
    Patil P; Agrawal M; Almelkar S; Jeengar MK; More A; Alagarasu K; Kumar NV; Mainkar PS; Parashar D; Cherian S
    Virol J; 2021 Feb; 18(1):47. PubMed ID: 33639977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral characterisation, antiviral activities, in silico ADMET and molecular docking of the compounds isolated from Tectona grandis to chikungunya virus.
    K S; Purushothaman I; S R
    Biomed Pharmacother; 2017 Mar; 87():302-310. PubMed ID: 28063412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of small molecule inhibitors of chikungunya virus proteins (nsP2 and E1) using
    Khan N; Bhat R; Patel AK; Ray P
    J Biomol Struct Dyn; 2021 Mar; 39(4):1373-1385. PubMed ID: 32072865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivirals against the Chikungunya Virus.
    Battisti V; Urban E; Langer T
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
    Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halogenated Secondary Metabolites from Higher Plants: Potent Drug Candidates for Chikungunya Using
    Kumar S; Joshi N; Choudhir G; Sharma S; Tiwari A; Alharbi SA; Alfarraj S; Ansari MJ
    Pol J Microbiol; 2024 Jun; 73(2):207-215. PubMed ID: 38905281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus.
    Nguyen PT; Yu H; Keller PA
    J Mol Model; 2014 May; 20(5):2216. PubMed ID: 24756552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Strategies for Inhibition of Chikungunya Infection.
    Subudhi BB; Chattopadhyay S; Mishra P; Kumar A
    Viruses; 2018 May; 10(5):. PubMed ID: 29751486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing approach against chikungunya virus: an
    Kasabe B; Ahire G; Patil P; Punekar M; Davuluri KS; Kakade M; Alagarasu K; Parashar D; Cherian S
    Front Cell Infect Microbiol; 2023; 13():1132538. PubMed ID: 37180434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.
    Dutta SK; Sengupta S; Tripathi A
    In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a theoretical model for the inhibition of nsP3 protease of Chikungunya virus using pyranooxazoles.
    Kumar D; Kumari K; Jayaraj A; Singh P
    J Biomol Struct Dyn; 2020 Jul; 38(10):3018-3034. PubMed ID: 31366291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.